Overview

Specified Drug Use-results Survey of Betanis Tablets

Status:
Completed
Trial end date:
2018-01-10
Target enrollment:
Participant gender:
Summary
To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mirabegron